FDA Clears SeptiCyte® RAPID - The First One-Hour, Direct-from-Blood Sepsis Test
/PRNewswire/ -- Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that SeptiCyte®...
Source: prnewswire.com